Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Wilson

Showing results (311-320 of 328) with videos related to

Pageof 33
Sort By:
Cell|August 14, 2018
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical SignaturesJoo Sang Lee, Lital Adler, Hiren Karathia, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2013
Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonistsDavid M Wilson, James Apps, Nicholas Bailey, et al.
JAMA Neurology|April 19, 2016
Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer DiseaseJennifer S Yokoyama, Yunpeng Wang, Andrew J Schork, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2020
Optimization of a series of potent, selective and orally bioavailable SYK inhibitorsNeil P Grimster, Lakshmaiah Gingipalli, Bernard Barlaam, et al.
Cancer Research|December 6, 2006
Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885Alastair J King, Denis R Patrick, Roberta S Batorsky, et al.
Journal of Medicinal Chemistry|January 16, 2016
Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate DerivativesSusan M Westaway, Alex G S Preston, Michael D Barker, et al.
ACS Chemical Biology|October 19, 2018
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6William McCoull, Tony Cheung, Erica Anderson, et al.
Nature Chemical Biology|January 27, 2015
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formationHuw D Lewis, John Liddle, Jim E Coote, et al.
Plos Medicine|March 22, 2017
Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard scoreRahul S Desikan, Chun Chieh Fan, Yunpeng Wang, et al.
Nature Communications|December 19, 2018
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemiaAdriana E Tron, Matthew A Belmonte, Ammar Adam, et al.
Pageof 33

Showing results (311-320 of 328) with videos related to

Sort By:
Pageof 33
Cell|August 14, 2018
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical SignaturesJoo Sang Lee, Lital Adler, Hiren Karathia, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2013
Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonistsDavid M Wilson, James Apps, Nicholas Bailey, et al.
JAMA Neurology|April 19, 2016
Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer DiseaseJennifer S Yokoyama, Yunpeng Wang, Andrew J Schork, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2020
Optimization of a series of potent, selective and orally bioavailable SYK inhibitorsNeil P Grimster, Lakshmaiah Gingipalli, Bernard Barlaam, et al.
Cancer Research|December 6, 2006
Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885Alastair J King, Denis R Patrick, Roberta S Batorsky, et al.
Journal of Medicinal Chemistry|January 16, 2016
Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate DerivativesSusan M Westaway, Alex G S Preston, Michael D Barker, et al.
ACS Chemical Biology|October 19, 2018
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6William McCoull, Tony Cheung, Erica Anderson, et al.
Nature Chemical Biology|January 27, 2015
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formationHuw D Lewis, John Liddle, Jim E Coote, et al.
Plos Medicine|March 22, 2017
Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard scoreRahul S Desikan, Chun Chieh Fan, Yunpeng Wang, et al.
Nature Communications|December 19, 2018
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemiaAdriana E Tron, Matthew A Belmonte, Ammar Adam, et al.
Pageof 33